Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity.
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity.